191 related articles for article (PubMed ID: 27257090)
1. Evaluating Ultra-long-Chain Fatty Acids as Biomarkers of Colorectal Cancer Risk.
Perttula K; Edmands WM; Grigoryan H; Cai X; Iavarone AT; Gunter MJ; Naccarati A; Polidoro S; Hubbard A; Vineis P; Rappaport SM
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1216-23. PubMed ID: 27257090
[TBL] [Abstract][Full Text] [Related]
2. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
[TBL] [Abstract][Full Text] [Related]
3. Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
Perttula K; Schiffman C; Edmands WMB; Petrick L; Grigoryan H; Cai X; Gunter MJ; Naccarati A; Polidoro S; Dudoit S; Vineis P; Rappaport SM
BMC Cancer; 2018 Oct; 18(1):996. PubMed ID: 30340609
[TBL] [Abstract][Full Text] [Related]
4. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
5. Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal Cancer.
Teras LR; Gapstur SM; Maliniak ML; Jacobs EJ; Gansler T; Michel A; Pawlita M; Waterboer T; Campbell PT
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):219-223. PubMed ID: 29254936
[No Abstract] [Full Text] [Related]
6. Red Blood Cell Fatty Acids and Risk of Colorectal Cancer in The European Prospective Investigation into Cancer and Nutrition (EPIC).
Linseisen J; Grundmann N; Zoller D; Kühn T; Jansen EHJM; Chajès V; Fedirko V; Weiderpass E; Dahm CC; Overvad K; Tjønneland A; Boutron-Ruault MC; Rothwell JA; Severi G; Kaaks R; Schulze MB; Aleksandrova K; Sieri S; Panico S; Tumino R; Masala G; De Marco L; Bueno-de-Mesquita B; Vermeulen R; Gram IT; Skeie G; Chirlaque MD; Ardanaz E; Agudo A; Sánchez MJ; Amiano P; Wennberg M; Bodén S; Perez-Cornago A; Aglago EK; Gunter MJ; Jenab M; Heath AK; Nieters A
Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):874-885. PubMed ID: 33619024
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum metabolites and colorectal cancer risk.
Cross AJ; Moore SC; Boca S; Huang WY; Xiong X; Stolzenberg-Solomon R; Sinha R; Sampson JN
Cancer; 2014 Oct; 120(19):3049-57. PubMed ID: 24894841
[TBL] [Abstract][Full Text] [Related]
8. Circulating Omentin as a Novel Biomarker for Colorectal Cancer Risk: Data from the EPIC-Potsdam Cohort Study.
Aleksandrova K; di Giuseppe R; Isermann B; Biemann R; Schulze M; Wittenbecher C; Fritsche A; Lehmann R; Menzel J; Weikert C; Pischon T; Boeing H
Cancer Res; 2016 Jul; 76(13):3862-71. PubMed ID: 27216184
[TBL] [Abstract][Full Text] [Related]
9. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
10. Serum fatty acid profiling of colorectal cancer by gas chromatography/mass spectrometry.
Kondo Y; Nishiumi S; Shinohara M; Hatano N; Ikeda A; Yoshie T; Kobayashi T; Shiomi Y; Irino Y; Takenawa T; Azuma T; Yoshida M
Biomark Med; 2011 Aug; 5(4):451-60. PubMed ID: 21861667
[TBL] [Abstract][Full Text] [Related]
11. Metabonomics identifies serum metabolite markers of colorectal cancer.
Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
[TBL] [Abstract][Full Text] [Related]
12. Reduction of novel circulating long-chain fatty acids in colorectal cancer patients is independent of tumor burden and correlates with age.
Ritchie SA; Heath D; Yamazaki Y; Grimmalt B; Kavianpour A; Krenitsky K; Elshoni H; Takemasa I; Miyake M; Sekimoto M; Monden M; Tomonaga T; Matsubara H; Sogawa K; Matsushita K; Nomura F; Goodenowe DB
BMC Gastroenterol; 2010 Nov; 10():140. PubMed ID: 21114854
[TBL] [Abstract][Full Text] [Related]
13. Circulating Long RNAs in Serum Extracellular Vesicles: Their Characterization and Potential Application as Biomarkers for Diagnosis of Colorectal Cancer.
Dong L; Lin W; Qi P; Xu MD; Wu X; Ni S; Huang D; Weng WW; Tan C; Sheng W; Zhou X; Du X
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1158-66. PubMed ID: 27197301
[TBL] [Abstract][Full Text] [Related]
14. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition.
Rinaldi S; Rohrmann S; Jenab M; Biessy C; Sieri S; Palli D; Tumino R; Mattiello A; Vineis P; Nieters A; Linseisen J; Pischon T; Boeing H; Hallmans G; Palmqvist R; Manjer J; Wirfält E; Crowe FL; Khaw KT; Bingham S; Tjønneland A; Olsen A; Overvad K; Lund E; Skeie G; Clavel-Chapelon F; Boutron-Ruault MC; de Lauzon-Guillain B; Ardanaz E; Jakszyn P; Ramon Quiros J; Chirlaque MD; Sanchez MJ; Dorronsoro M; Trichopoulou A; Lagiou P; Trichopoulos D; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Slimani N; Ferrari P; Byrnes GB; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3108-15. PubMed ID: 18990751
[TBL] [Abstract][Full Text] [Related]
15. Sex-Specific Association between Family History of Diabetes and Risk of Colorectal Cancer: Two Prospective Cohort Studies.
Ma W; Song M; Kværner AS; Prescott J; Chan AT; Giovannucci EL; Zhang X
Cancer Prev Res (Phila); 2018 Sep; 11(9):535-544. PubMed ID: 29991578
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of polyunsaturated fatty acids and risk of colorectal cancer: a prospective study.
Kojima M; Wakai K; Tokudome S; Suzuki K; Tamakoshi K; Watanabe Y; Kawado M; Hashimoto S; Hayakawa N; Ozasa K; Toyoshima H; Suzuki S; Ito Y; Tamakoshi A;
Am J Epidemiol; 2005 Mar; 161(5):462-71. PubMed ID: 15718482
[TBL] [Abstract][Full Text] [Related]
17. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study.
Palmqvist R; Engarås B; Lindmark G; Hallmans G; Tavelin B; Nilsson O; Hammarström S; Hafström L
Dis Colon Rectum; 2003 Nov; 46(11):1538-44. PubMed ID: 14605576
[TBL] [Abstract][Full Text] [Related]
18. Blood levels of long-chain polyunsaturated fatty acids, aspirin, and the risk of colorectal cancer.
Hall MN; Campos H; Li H; Sesso HD; Stampfer MJ; Willett WC; Ma J
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):314-21. PubMed ID: 17301265
[TBL] [Abstract][Full Text] [Related]
19. Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids.
Kuriki K; Wakai K; Hirose K; Matsuo K; Ito H; Suzuki T; Saito T; Kanemitsu Y; Hirai T; Kato T; Tatematsu M; Tajima K
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1791-8. PubMed ID: 17035384
[TBL] [Abstract][Full Text] [Related]
20. Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk.
Touvier M; Fezeu L; Ahluwalia N; Julia C; Charnaux N; Sutton A; Méjean C; Latino-Martel P; Hercberg S; Galan P; Czernichow S
World J Gastroenterol; 2012 Jun; 18(22):2805-12. PubMed ID: 22719189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
